Insulin degludec/liraglutide
Insulin degludec/liraglutide
Insulin degludec/liraglutide (pronunciation: IN-su-lin DEG-loo-dek/LIR-a-gloo-tide) is a combination medication used in the treatment of Type 2 diabetes. It is a combination of two drugs: insulin degludec, a long-acting insulin, and liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist.
Etymology
The term "insulin" is derived from the Latin insula, meaning "island", referring to the insulin-producing islets of Langerhans in the pancreas. The term "degludec" is a proprietary name for a specific long-acting insulin formulation. "Liraglutide" is derived from the Latin glutire, meaning "to swallow", and lira, meaning "a mark or line", referring to the drug's mechanism of action and its administration via injection.
Usage
Insulin degludec/liraglutide is used to improve blood sugar control in adults with type 2 diabetes. It is used when diet and exercise alone does not control blood sugar. Insulin degludec is a long-acting insulin that works by replacing the insulin that is normally produced by the body and by helping move sugar from the blood into other body tissues where it is used for energy. Liraglutide works by stimulating the release of insulin and reducing the amount of glucose produced and released by the liver.
Related Terms
- Type 2 diabetes
- Insulin
- Liraglutide
- Insulin degludec
- Glucagon-like peptide-1 (GLP-1) receptor agonist
- Blood sugar control
- Islets of Langerhans
See Also
External links
- Medical encyclopedia article on Insulin degludec/liraglutide
- Wikipedia's article - Insulin degludec/liraglutide
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski